Summary
- Current Price
- As of today, NRXP price is $3.27, down -2.10% on
- Current Price All-Time High
- NRXP price is currently -99.58% below its historical high of $769.90 set on
- Market Cap
- NRXP current market cap is $140M, up +169.18% over the past 365 days
- Revenue
- NRXP current annual revenue is $1.23M, up +100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for NRXP has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | NRx Pharmaceuticals, Inc. |
| Ticker | NASDAQ: NRXP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nrxpharma.com |
| Employees | 29 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $3.27 | ||
| Price, 1D Change | -2.10% | |
| $140M | ||
| - | ||
| - | ||
| 2.12 | ||
| $1.23M | ||
| Revenue, 1Y Change | +100.00% | |
| -$1.34 | ||
| EPS, 1Y Change | +43.34% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BRPA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.34 | ||
| EPS Estimate | -$0.36 | N/A |
| EPS Est. Change | +73.08% | N/A |
| $1.23M | ||
| Revenue Estimate | $10.19M | N/A |
| Revenue Est. Change | +731.97% | N/A |
| $3.27 | ||
| Price Target | $49.00 | - |
| Price Tgt. Change | +1,398.47% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.86 | -$2.36 | -27.25% | |
| -$1.42 | -$1.34 | +5.82% | |
| -$0.36 | N/A | +73.08% | |
| $0.50 | N/A | +137.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $11.81M | $1.23M | -89.63% | |
| $10.19M | N/A | +731.97% | |
| $204.07M | N/A | +16,558.50% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +22.47% | ||
| -1.21% | ||
| +169.18% | ||
| +425.99% | ||
| +100.00% | ||
| +100.00% | ||
| +43.34% | ||
| +77.87% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $3.27 | ||
| $2.79 | ||
| $3.82 | ||
| $3.08 | ||
| $3.60 | ||
| -$0.18 | ||
| 2.12 | ||
| $0.34 | ||
| 41.98 | ||
| 97.34% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $1.23M | ||
| -$1.34 | ||
| $577.00K | ||
| 47.10% | ||
| -$16.19M | ||
| -1,321.47% | ||
| -$28.62M | ||
| -2,336.49% | ||
| -$16.05M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -0.04 | ||
| 0.31 | ||
| 0.31 | ||
| - | ||
| - | ||
| -36.11 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 61.04 | ||
| -10.13 | ||
| -7.95 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$15.94M | ||
| $7.80M | ||
| $12.96M | ||
| $8.89M | ||
| $28.89M | ||
| $28.58M | ||
| $631.00K | ||
| $316.00K | ||
| $4.27M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $29.85M | ||
| $16.77M | ||
| $648.00K | ||
| $0.00 | ||
| $143.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$14.11M | ||
| -$2.81M | ||
| $23.28M | ||
| $0.00 | ||
| -$14.11M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| BTIG | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| Ascendiant Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| BTIG | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with NRXP
FAQ
- What is the ticker symbol for NRx Pharmaceuticals, Inc.?
- The ticker symbol for NRx Pharmaceuticals, Inc. is NASDAQ:NRXP
- Does NRx Pharmaceuticals, Inc. pay dividends?
- No, NRx Pharmaceuticals, Inc. does not pay dividends
- What sector is NRx Pharmaceuticals, Inc. in?
- NRx Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is NRx Pharmaceuticals, Inc. in?
- NRx Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is NRx Pharmaceuticals, Inc. based in?
- NRx Pharmaceuticals, Inc. is headquartered in United States
- When did NRx Pharmaceuticals, Inc. go public?
- NRx Pharmaceuticals, Inc. initial public offering (IPO) was on December 4, 2017
- Is NRx Pharmaceuticals, Inc. in the S&P 500?
- No, NRx Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is NRx Pharmaceuticals, Inc. in the NASDAQ 100?
- No, NRx Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is NRx Pharmaceuticals, Inc. in the Dow Jones?
- No, NRx Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was NRx Pharmaceuticals, Inc. last earnings report?
- NRx Pharmaceuticals, Inc.'s most recent earnings report was on August 14, 2026
- When does NRx Pharmaceuticals, Inc. report earnings?
- The date for NRx Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- NRXP Official Website www.nrxpharma.com
- NRXP Profile on Yahoo Finance finance.yahoo.com/quote/NRXP
- NRXP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nrxp